Entry |
|
Name |
Clorazepate monopotassium (USAN) |
Formula |
C16H10ClN2O3. K
|
Exact mass |
352.0017
|
Mol weight |
352.81
|
Structure |

|
Simcomp |
|
Class |
Neuropsychiatric agent
DG01914 Anxiolytics, benzodiazepine derivatives
|
Remark |
Product (DG01218): | D00694<JP/US> |
|
Efficacy |
Minor tranquilizer |
Comment |
Benzodiazepine derivative
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Interaction |
|
Structure map |
map07230 | GABA-A receptor agonists/antagonists |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N05 PSYCHOLEPTICS
N05B ANXIOLYTICS
N05BA Benzodiazepine derivatives
N05BA05 Potassium clorazepate
D03562 Clorazepate monopotassium (USAN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01914 Anxiolytics, benzodiazepine derivatives
DG01218 Clorazepic acid
D03562 Clorazepate monopotassium
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
GABA (ionotropic)
GABR
D03562 Clorazepate monopotassium (USAN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01914 Anxiolytics, benzodiazepine derivatives
DG01218 Clorazepic acid
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 23
1 C2y C 23.6628 -14.2949
2 C8y C 22.8204 -13.1849
3 C8y C 23.1557 -11.8276
4 N1x N 24.4172 -11.2493
5 N2x N 25.0692 -14.2501
6 C5x C 25.6713 -11.8718
7 C1y C 25.9579 -13.2410
8 C8x C 22.1482 -10.8588
9 C8x C 20.8057 -11.2471
10 C8y C 20.4704 -12.6044
11 C8x C 21.4779 -13.5729
12 X Cl 19.1051 -12.9989
13 C8y C 23.0281 -15.5451
14 C8x C 21.6259 -15.5451
15 C8x C 20.9257 -16.7581
16 C8x C 21.6259 -17.9710
17 C8x C 23.0281 -17.9710
18 C8x C 23.7284 -16.7581
19 C6a C 27.1709 -13.9413
20 O6a O 28.3838 -13.2410 #-
21 O5x O 26.7809 -11.0138
22 O6a O 27.1709 -15.3359
23 Z K 29.8318 -13.3052 #+
BOND 24
1 3 4 1
2 1 5 2
3 4 6 1
4 2 3 1
5 5 7 1
6 1 2 1
7 6 7 1
8 3 8 2
9 8 9 1
10 9 10 2
11 10 11 1
12 2 11 2
13 10 12 1
14 1 13 1
15 13 14 1
16 14 15 2
17 15 16 1
18 16 17 2
19 17 18 1
20 13 18 2
21 7 19 1
22 19 20 1
23 6 21 2
24 19 22 2
|